MaxCyte Inc. (NASDAQ: MXCT) operates under the executive leadership of Maher Masoud, who serves as the President and Chief Executive Officer. Having taken the helm of the cell-engineering technology enterprise, he manages its corporate growth, strategic biopharmaceutical licensing partnerships, and innovative electroporation platform expansions across global life science markets.